MedElevator
Войти в исследования American journal of otolaryngology · 2026
Modern advances in parathyroid surgery: A survey of North American surgeon associations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Staibano Phillip, Au Michael, Zhang Han, Pasternak Jesse D, Busse Jason W, Parpia Sameer, Orloff Lisa, Seib Carolyn D, Nguyen Nhu-Tram, Monteiro Eric, McKechnie Tyler, Thabane Alex, Gupta Michael K, Choi David L, van der Woerd Benjamin, Lewis Trevor A, Young J E, Bhandari Mohit
Аннотация
BACKGROUND: Contemporary clinical guidelines recommend the use of intraoperative parathyroid hormone (IOPTH) when treating parathyroid disease, yet the degree to which parathyroid surgeons adhere to this, and other guideline recommendations remains unknown. To evaluate parathyroid surgeon practices when managing primary (PHPT), secondary (SHPT), and tertiary (THPT) hyperparathyroidism.
METHODS: A cross-sectional electronic survey characterizing parathyroid surgery practices was conducted according to CHEERS and AAPOR guidance and distributed to four North American surgeon societies from August-November 2024. The survey evaluated surgeon demographics, imaging practices, and surgical adjunct use. The primary outcome was the use of IOPTH. Descriptive and multivariable logistic regression analyses were used to explore parathyroid surgery practices and characteristics predictive of using IOPTH.
RESULTS: 523 surgeons responded to this survey (response rate: 70.5%, range: 59.9%-85.7%). Most surgeons were from the US and Canada, while 56.3% of respondents were trained in otolaryngology-head and neck surgery. Ultrasonography was the most used modality, while IOPTH was most often used to guide parathyroid surgery [(376/426), 88.3%]. Intraoperative radioguidance and autofluorescence were used infrequently. IOPTH was used by US surgeons [adjusted odds ratio (aOR): 20.1; 95% CI: 1.9, 164.9; p < 0.01] who trained using IOPTH (aOR: 4.7; 95% CI: 1.2, 21.4; p < 0.05). Surveyed surgeons often used the Miami or modified Miami criteria when performing surgery for PHPT, while almost 30% of surgeons reported not using any IOPTH criteria during surgery for SHPT or THPT.
CONCLUSIONS: Surgeons adhere to clinical guidelines when managing parathyroid disease, especially with reference to IOPTH in minimally invasive parathyroidectomy. Practice heterogeneity, however, exists with reference to parathyroid imaging and the use of intraoperative adjuncts for parathyroid surgery in parathyroid disease, especially SHPT and THPT.
METHODS: A cross-sectional electronic survey characterizing parathyroid surgery practices was conducted according to CHEERS and AAPOR guidance and distributed to four North American surgeon societies from August-November 2024. The survey evaluated surgeon demographics, imaging practices, and surgical adjunct use. The primary outcome was the use of IOPTH. Descriptive and multivariable logistic regression analyses were used to explore parathyroid surgery practices and characteristics predictive of using IOPTH.
RESULTS: 523 surgeons responded to this survey (response rate: 70.5%, range: 59.9%-85.7%). Most surgeons were from the US and Canada, while 56.3% of respondents were trained in otolaryngology-head and neck surgery. Ultrasonography was the most used modality, while IOPTH was most often used to guide parathyroid surgery [(376/426), 88.3%]. Intraoperative radioguidance and autofluorescence were used infrequently. IOPTH was used by US surgeons [adjusted odds ratio (aOR): 20.1; 95% CI: 1.9, 164.9; p < 0.01] who trained using IOPTH (aOR: 4.7; 95% CI: 1.2, 21.4; p < 0.05). Surveyed surgeons often used the Miami or modified Miami criteria when performing surgery for PHPT, while almost 30% of surgeons reported not using any IOPTH criteria during surgery for SHPT or THPT.
CONCLUSIONS: Surgeons adhere to clinical guidelines when managing parathyroid disease, especially with reference to IOPTH in minimally invasive parathyroidectomy. Practice heterogeneity, however, exists with reference to parathyroid imaging and the use of intraoperative adjuncts for parathyroid surgery in parathyroid disease, especially SHPT and THPT.